Immune thrombocytopenia, or ITP, has been recognized as a clinical entity for centuries, and
the importance of humoral mechanisms in the pathophysiology of ITP has been recognized …

Immune thrombocytopenia (ITP) is an autoimmune disorder defined by a significantly
reduced number of platelets in blood circulation. Due to low levels of platelets, ITP is …

Traditional treatment of primary (idiopathic) immune thrombocytopenia (ITP) predominantly
consists of immune suppression and/or modulation. In addition, many treated patients …

Immune thrombocytopenia (ITP) comprises a heterogeneous group of disorders
characterized by autoimmune-mediated platelet destruction and impairment of …

Immune thrombocytopenia (ITP) is a rare autoimmune condition, due to peripheral platelet
destruction through antibody-dependent cellular phagocytosis, complement-dependent …

There are not many publications that provide a holistic view of the management of primary
and secondary ITP as a whole, reflecting the similarities and differences between the two …

Background Immune thrombocytopenia (ITP) is a heterogeneous acquired disorder
characterized by isolated thrombocytopenia whose exact pathogenesis is not yet clear …

Immune thrombocytopenia (ITP) is a rare autoimmune disorder with an incidence of 3 to 5
per 100 000 individuals. In children, the disease is self-limited and is most commonly virus …

Immune thrombocytopenia (ITP) is an autoimmune-mediated condition that results from
antibody-mediated destruction of platelets and impaired megakaryocyte platelet production …

Primary immune thrombocytopenia is an autoimmune disorder of unknown cause affecting
both children and adults. The low peripheral blood platelet count is caused by premature …